386 related articles for article (PubMed ID: 8056047)
21. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
Tatsumi E
Hum Cell; 1992 Mar; 5(1):79-86. PubMed ID: 1329932
[TBL] [Abstract][Full Text] [Related]
23. Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus.
Baran-Marszak F; Laguillier C; Youlyouz I; Feuillard J; Mariette X; Fagard R; Raphaël M
Cytokine; 2006 Mar; 33(6):337-45. PubMed ID: 16713282
[TBL] [Abstract][Full Text] [Related]
24. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.
Miyauchi K; Urano E; Yoshiyama H; Komano J
Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167
[TBL] [Abstract][Full Text] [Related]
25. Production and regulation of interleukin 6 in human B lymphoid cells.
Hutchins D; Cohen BB; Steel CM
Eur J Immunol; 1990 May; 20(5):961-8. PubMed ID: 2113479
[TBL] [Abstract][Full Text] [Related]
26. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
[TBL] [Abstract][Full Text] [Related]
27. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
[TBL] [Abstract][Full Text] [Related]
28. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
[TBL] [Abstract][Full Text] [Related]
29. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines.
Sinclair AJ; Jacquemin MG; Brooks L; Shanahan F; Brimmell M; Rowe M; Farrell PJ
Virology; 1994 Mar; 199(2):339-53. PubMed ID: 8122366
[TBL] [Abstract][Full Text] [Related]
30. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
[TBL] [Abstract][Full Text] [Related]
31. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
[TBL] [Abstract][Full Text] [Related]
32. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities.
Medvedev AE; Sundan A; Espevik T
Eur J Immunol; 1994 Nov; 24(11):2842-9. PubMed ID: 7957575
[TBL] [Abstract][Full Text] [Related]
34. Human B-lymphoid cell lines.
Nilsson K
Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
[TBL] [Abstract][Full Text] [Related]
35. Expression of interleukin 10 in B lymphocytes of different origin.
Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
[TBL] [Abstract][Full Text] [Related]
36. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.
Mackay F; Majeau GR; Lawton P; Hochman PS; Browning JL
Eur J Immunol; 1997 Aug; 27(8):2033-42. PubMed ID: 9295042
[TBL] [Abstract][Full Text] [Related]
37. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells.
Vey E; Burger D; Dayer JM
Eur J Immunol; 1996 Oct; 26(10):2404-9. PubMed ID: 8898953
[TBL] [Abstract][Full Text] [Related]
38. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells.
Amrani Y; Panettieri RA; Frossard N; Bronner C
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):55-63. PubMed ID: 8679222
[TBL] [Abstract][Full Text] [Related]
39. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis.
Samanta M; Takada K
Cancer Sci; 2010 Jan; 101(1):29-35. PubMed ID: 19886912
[TBL] [Abstract][Full Text] [Related]
40. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
Avila-Carino J; Torsteinsdottir S; Bejarano MT; Klein G; Klein E; Masucci MG
Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
